{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["19(3)"],"submitter":["Roucoux G"],"funding":["Agence Nationale de Recherches sur le Sida et les Hépatites Virales"],"pubmed_abstract":["<h4>Introduction</h4>Clinical research has focused on risk factors and treatment for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), particularly in people with a comorbidity including the human immunodeficiency virus (HIV), but little attention has been paid to the care pathway. This article aims to show how living with HIV may have been a biopsychosocial burden or boost in care pathways for Covid-19.<h4>Method</h4>People living with HIV (PLHIV) from 9 clinical centers were invited to participate in this qualitative study. The sampling was purposive with a maximum variation in their sociodemographic profiles. Semi-structured interviews were conducted until data saturation, then coded for thematic analysis, using an inductive general approach.<h4>Results</h4>We interviewed 34"],"journal":["PloS one"],"pagination":["e0295223"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10919596"],"repository":["biostudies-literature"],"pubmed_title":["Questioning the \"Ease\" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)."],"pmcid":["PMC10919596"],"pubmed_authors":["Duracinsky M","Roucoux G","Cheret A","Zucman D","Rey D","Eriksson LE","Preau M","Michels D","Thonon F","Abgrall S"],"additional_accession":[]},"is_claimable":false,"name":"Questioning the \"Ease\" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV).","description":"<h4>Introduction</h4>Clinical research has focused on risk factors and treatment for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), particularly in people with a comorbidity including the human immunodeficiency virus (HIV), but little attention has been paid to the care pathway. This article aims to show how living with HIV may have been a biopsychosocial burden or boost in care pathways for Covid-19.<h4>Method</h4>People living with HIV (PLHIV) from 9 clinical centers were invited to participate in this qualitative study. The sampling was purposive with a maximum variation in their sociodemographic profiles. Semi-structured interviews were conducted until data saturation, then coded for thematic analysis, using an inductive general approach.<h4>Results</h4>We interviewed 34","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2026-06-12T10:07:30.805Z","creation":"2025-04-04T12:34:50.796Z"},"accession":"S-EPMC10919596","cross_references":{"pubmed":["38452028"],"doi":["10.1371/journal.pone.0295223"]}}